InvestorsHub Logo
icon url

Rdunn88

10/14/21 10:57 PM

#378671 RE: Lemoncat #378666

Shouldn’t one look at today’s filing as based on performance? If they miss data it doesn’t matter. Actually I view this as positive. A sale or known good data.
icon url

steelyeye

10/15/21 12:27 AM

#378678 RE: Lemoncat #378666

How could it be otherwise? At this stage with a platform drug in Brilacidin and likely good PH II results.

Save your sadness and "greedy Leo" refrain until we see what's in store.



Every one of those milestones better have a share price of $5+.